Linc Energy Ltd. ADS (LNCGY) Financials Nov 14, 2014, 4:00
Linc Energy Ltd. ADS (LNCGY) Financials Nov 14, 2014, 4:00 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Linc Energy Ltd. ADS
Fiscal year is July-June. All values SGD millions. 2010 2011 2012 2013 2014 5-year trend
Sales/Revenue 2.51M 4.08M 74.13M 158.11M 171.61M
Cost of Goods Sold (COGS) incl. D&A 29.55M 21.94M 57.67M 87.83M 140.43M
COGS excluding D&A 5.25M 6.05M 31.07M 42.43M 47.01M
Depreciation & Amortization Expense 24.3M 15.88M 26.6M 45.4M 93.42M
Depreciation 1.07M 1.76M 18.4M 42.5M 90.26M
Amortization of Intangibles 23.24M 14.12M 8.2M 2.9M 3.15M
Gross Income (27.05M) (17.85M) 16.46M 70.28M 31.18M
2010 2011 2012 2013 2014 5-year trend
SG&A Expense 46.89M 98.84M 124.44M 99.12M 107.24M
Research & Development 16.71M 25.03M 31.99M 23.47M 631,453
Other SG&A 30.17M 73.81M 92.45M 75.65M 106.61M
Other Operating Expense 0 0 0 0 16.17M
Unusual Expense 0 - 7.6M (4.76M) 91.75M
EBIT after Unusual Expense 0 - (7.6M) 4.76M (91.75M)
Non Operating Income/Expense 354,189 640.48M 3.79M (28.41M) 2.42M
Non-Operating Interest Income 1.1M 28.3M 4.65M 859,367 1.42M
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 6.69M 526,926 9.38M 57.69M 81.31M
Gross Interest Expense 6.69M 526,926 9.38M 57.69M 81.31M
Interest Capitalized 0 0 0 0 0
Pretax Income (79.17M) 551.56M (116.53M) (109.31M) (261.45M)
Income Tax (59.04M) 173.34M (36.12M) (28.17M) 3.95M
Income Tax - Current Domestic - 53.63M (33.21M) (43.05M) 25.31M
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic - 119.71M (2.91M) 14.88M (21.37M)
Income Tax - Deferred Foreign - - - - -
Income Tax Credits - 0 0 0 0
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (20.13M) 378.21M (80.41M) (81.14M) (265.39M)
Minority Interest Expense (3,715) (17,862) (2,598) (25,425) (2.66M)
Net Income (20.13M) 378.23M (80.41M) (81.11M) (262.74M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg - 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (20.13M) 378.23M (80.41M) (81.11M) (262.74M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (20.13M) 378.23M (80.41M) (81.11M) (262.74M)
EPS (Basic) (0.04) 0.76 (0.16) (0.16) (0.48)
Basic Shares Outstanding 466.52M 500.2M 508.14M 514.71M 551.33M
EPS (Diluted) (0.04) 0.74 (0.16) (0.16) (0.48)
Diluted Shares Outstanding 466.52M 513.72M 508.14M 514.71M 551.33M
EBITDA (49.63M) (100.81M) (81.39M) 16.56M 1.19M
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...
Continue Reading
Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...
Continue Reading
Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...
Continue Reading
A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...
Continue Reading
Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...
Continue Reading
Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...
Continue Reading
Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...
Continue Reading
New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...
Continue Reading
Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...
Continue Reading
Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...
Continue Reading
Top 5 Most Recently Viewed Articles
Grand Circle Cruise Line Recognized Among the Best Grand Circle Cruise Line (GCCL) recently earned the impressive title of #2 Best River Cruise Line in the Travel + Leisure's 2025 World's Best Awards. This accolade showcases the hard work and dedication of the teams and crew members who make each journey remarkable along Europe’s scenic rivers. Celebrating a Special...
Continue Reading
Lancaster Resources Secures Approval for Exploration License Vancouver-based Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) is pleased to announce a significant milestone in its gold exploration journey. The company has received confirmation of an Exploration License for the Lake Cargelligo Gold Project from the State of New South Wales. Covering an impressive...
Continue Reading
Understanding the Vitrectomy Devices Market Growth The vitrectomy devices industry has become increasingly vital in treating various eye-related disorders, with significant growth projected in the coming years. By focusing on technological advancements and heightened awareness of eye health, the market is set to expand impressively. According to a recent report, the...
Continue Reading
Understanding RDG Mining's Latest Offerings In recent times, the popularity of cryptocurrency has surged significantly, with platforms like RDG Mining capitalizing on this trend. RDG Mining is a leading cloud mining service based in the UK that has captured the interest of over 7.5 million users globally, particularly with the rise in various cryptocurrencies, including...
Continue Reading
Revisions to Financial Reporting and Calendar The board of Pharma Equity Group A/S has recently made the strategic decision to submit only half-yearly financial reports moving forward. This adjustment reflects a shift in focus towards more impactful reporting. As a result, the financial calendar for 2025 has been updated to better align with these new reporting practices....
Continue Reading